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M. Ghasemi,1 S.H. Fesharaki2 and M. Sanatkar1*1Invasive Cardiology Department, and 2 Neurology Department, Sasan General Hospital, Tehran, IranSymptomatic basilar artery stenosis has a poor prognosis. Surgical bypasses are technically demanding and of no proven
benefit. A new generation of intravascular stents that are flexible enough to navigate the tortuosities of the vertebral artery
may provide a new therapeutic approach. We report two cases of vertebrobasilar ischemia with repeat vertigo and falls.
Magnetic resonance angiography revealed severe middle basilar artery stenosis in case 1. A Transcranial Doppler (TCD)
showed severe vertebrobasilar artery stenosis in the second case. The patients underwent uncomplicated angioplasty and
stenting of the basilar arteries. The patients were well and free of symptoms after 12 months and 8 months follow up,
respectively. The new flexible intravascular stents may provide a novel therapeutic approach for patients with basilar artery
stenosis.Keywords: Basilar artery; Vertebral artery; Angioplasty; Stenting.Introduction
The outcome of symptomatic basilar artery stenosis is
poor, with most patients experiencing significant
morbidity or death from recurrent ischemic events,
despite optimal medical therapy.1–4 Surgical therapy is
technically demanding, associated with considerable
morbidity and significant rates of complication and
failure.3,5,6 Angioplasty of basilar artery stenosis has
been proposed as a novel therapeutic approach.7–9
Although, there have been some encouraging results,
intraplaque dissection, plaque dislodgment, and
vessel recoil with restenosis may occur.10–12 Other
authors showed that the restenosis rate after intracra-
nial angioplasty is high.13 Percutaneous angioplasty of
the intracranial arteries still carries the risk of
dissection, with acute closure and embolization.14
The advantages of stent-assisted angioplasty over
angioplasty alone include the exclusion of dislodged
plaque and regions of dissection from the vessel
lumen, as well as the prevention of vessel recoil and
rupture.12 We describe two patients with angioplasty
and stenting for a symptomatic atherosclerotic steno-
sis of the basilar arteries.ing author. Dr Mehdi Sanatkar, Invasive Cardiology
Imam Khomeini Medical Center, Sasan General
vd. Keshavarz, Tehran, Iran.
: mehdi_sanatkar@yahoo.com
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The 57 year-old man with history of hypertension and
history of recurrent vertigo and repeat drop attack
referred in October 2003 to our institution for
angioplasty of a basilar artery stenosis. Brain magnetic
resonance imaging scans showed no infarction within
the territories of both posterior cerebral arteries.
Magnetic resonance angiography showed severe
middle basilar artery stenosis. The patient was given
warfarin therapy. Our patient did not recover com-
pletely and he continued to experience daily episodes
of vertigo and drop attacks. Cerebral angiography
confirmed the presence of high-grade middle basilar
artery stenosis (Fig. 1(A)).Case 2
The 52 year-old man with history of repeat severe
vertigo and falls referred in March 2004 for angio-
plasty of a basilar artery stenosis. Brain magnetic
resonance imaging scans showed no infarction within
the distal field territories of both posterior cerebral
arteries. Transcranial Doppler showed severe stenosis
in proximal of basilar artery. The patient was given
warfarin therapy. Our patient did not recover com-
pletely by medical therapy. Cerebral angiographyEJVES Extra 11, 103–106 (2006)
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Fig. 1. (A) Left vertebral angiogram shows middle basilar
artery stenosis (arrow). (B) Radiograph shows navigation
of 0.014-in. guidewire and AVE S7 coronary stent,
Medtronic into left vertebral artery. Stent was smoothly
navigated into middle basilar artery (arrow). (C) Final left
vertebrobasilar control angiogram shows stent deployed
into basilar artery. No residual stenosis is visible (arrow).
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EJVES Extra Vol 11, June 2006confirmed a large plaque with severe stenosis in distal
of left vertebral artery and proximal of the basilar
artery (Fig. 2(A)).Operative technique
After the insertion of a 7-French femoral sheath,
5000 U of heparin was injected IV followed by a
continuous infusion of 3000 U/h to obtain an activated
clotting time at 200 s. Two hundred and fifty
milligrams of acetylsalicylic acid and 400 mg Clopido-
grel were also given. A 7-French right coronary guide
catheter was placed over an exchange wire in the
proximal vertebral arteries. A 0.014-in. guidewire was
then navigated across the basilar arteries stenosis, and
the guidewire tip was secured into the left posterior
cerebral artery. The pressures immediately proximal to
the stenotic lesion were measured (120 mmHg in case
1 and 140 mmHg in case 2). The microguidewire and
microcatheter were then advanced through the
stenosis. Pressure measurements distal to the stenotic
lesions revealed a significant gradient across the
stenosis. Angioplasty predilation was performed
with a 2.0!15 mm2 balloon in case 1 and 2.5!
20 mm2 balloon in case 2. A balloon-expandable
coronary stent with a diameter of 3.0 mm and a length
of 18 mm (Medtronic AVE, S7; coronary stent, for case
1 and AVE, driver; coronary stent, for case 2) was
deployed with no residual stenosis. (Figs. 1(B) and
2(B)). The second patient experienced a syncopal
episode during balloon inflation. The episode resolved
immediately after balloon deflation. A control angio-
gram showed the stents mesh covering the entire
atherosclerotic basilar segments and excellent basilar
arteries patency, with no residual stenosis (Figs. 1(C)
and 2(C)). The proximal margin of the stent extended
1 mm into the left vertebral artery in case 2. However,
patency of the right vertebral artery outflow was not
impaired. No complications occurred during or after
the stents deployment. Continuous intravenous
heparin infusion was administered for 12 h after the
procedure, to maintain a partial thromboplastin time
1.5–2.0 times the normal value. The same day, 250 mg
of aspirin and 400 mg of Clopidogrel were adminis-
tered and continued for 6 months. During follow-up
(12 months in case 1 and 8 months in case 2), the
patients were well and free of symptoms.Discussion
Symptomatic verterbrobasilar artery stenosis portends
a poor prognosis with medical therapy.3 Patients with
Fig. 2. (A) Left vertebral angiogram shows distal vertebral
artery and proximal basilar artery stenosis (arrows). (B)
Radiograph shows navigation of 0.014-in. guidewire and
AVE; driver coronary stent, Medtronic into left vertebral
artery. Stent was smoothly navigated into proximal basilar
artery (arrow). (C) Final left vertebrobasilar control angio-
gram shows stent deployed into distal of vertebral and
proximal of basilar artery. No residual stenosis is visible
(arrow).
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tic occlusive disease have few therapeutic options.
Unfortunately, VBA transient ischemic attacks (TIAs)
herald a lethal or devastating event within 5 years in
25–30% of patients.15 Anticoagulation and antiplatelet
therapy has been proposed to prevent acute basilar
artery thrombosis and its catastrophic consequences.
A recent randomized study suggested that the
administration of prescription drugs is inadequate.16
Further atheromatosis progression was not stalled by
long-term therapy, and stroke rates reported for
patients with basilar artery stenoses on anticoagula-
tive therapy were as high as 10% per year. This
observation lead to the suggestion that aggressive
therapy such as angioplasty should be considered for
high-grade stenoses.17 Until recently, intracranial
stenting was limited by the rigidity of available
devices, making navigation through the tortuous
proximal intracranial circulation difficult. The avail-
ability of intravascular stents that can be navigated
through tortuous intracranial vessels has initiated a
new era in endovascular therapy.11,16
Endovascular treatment of basilar artery stenosis
has been advocated for recurrent symptoms that are
refractory to medical treatment.7,9,18 It may be offered
routinely as an alternative therapy to patients with
medically refractory posterior circulation disease that
may develop catastrophic VBA insufficiency.15 Vessel
tortuosity and compromise of the brainstem perfora-
tors originating from the basilar artery are less
common problems with proximal stenoses.17 A slow
and undersized dilation of the stenosis are necessary
to protect vessels that do not have supporting tissue, in
order to prevent a sudden rupture, intimal dissection,
acute vasospasm, or thrombosis. However, the
likelihood of such potentially dramatic complications
may be minimized by stent implantation, which also
allows a more aggressive anatomic correction.17,19
Stents have been used in the treatment of intracranial
carotid stenosis, with encouraging results.20–22 Two
reports have suggested that stent-assisted angioplasty
may represent a viable therapeutic option for vertebral
artery and basilar artery atheromatous stenoses.19,23
Our cases suggest that stent-assisted angioplasty may
represent a viable therapeutic option for patients with
basilar artery stenosis. However, antithrombotic medi-
cation in cerebral angioplasty has not been standar-
dized and antiplatelet regimens administered during
and after intracranial stenting remain empirical.17 The
use of acetylsalicylic acid and Clopidogrel and stent
implantation may also confer complementary long-
term clinical benefits for patients undergoing intracra-
nial angioplasty, similar to benefits for patients under-
going coronary stenting.24 New treatments modalities,EJVES Extra Vol 11, June 2006
M. Ghasemi et al.106such as the use of direct thrombin inhibitors and
antibodies to platelet glycoprotein IIb/IIIa, seem to be
more effective for prophylaxis and treatment than
conventional anticoagulation and ant platelet thera-
pies.25 There is concern that occlusion of the ostia of
small side branches and perforating arteries by stent
placement may result in ischemia or infarction in the
territory of these vessels.12 However, experimental
evidence suggests that small lateral carotid branches
in dogs, which approximate human intracranial
perforating vessels with respect to their diameter
and angle of origin, tend to remain patent if less than
50% of the ostial diameter is covered by the stent
struts.12,24 Similarly, no difficulties involving perforat-
ing branch occlusions were encountered after stenting
in our cases. Our procedures were balloon angioplasty
to predilate the lesions. Subsequently the delivered the
balloon-expandable stent was deployed. Long-term
follow-up data and additional clinical experience are
required to effectively assess this novel approach for
the treatment of vertebrobasilar occlusive disease.Acknowledgements
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